Out-licensing: Hospital And Surgery

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 11..20 of 73 - per page Previous page Next page
Order by

APR BioFilm

Biotechnology Product for Wound Healing More

SAVENE™ for anthracycline extravasation

Niche oncology marketing opportunity More

Iodine as Antiseptic for Dental Use

Thermal Skin Burns. Civil: Treatment of Thermal Skin Burns. Keywords: formulation More

Hyaloglide®

Hyaluronan based gel for prevention and reduction of adhesion formation in tendon and nerve surgery More

ImmLab's primary product: A Therapeutic Staphylococcal Lysate (SL) as described in our patent 6,929,798 and 7,329,409 granted by the U.S. Patent and Trademark Office

SL is prepared by lysis of S. aureus culture with a polyvalent bacteriophage. More

A new treatment for diarrhoea and endotoxaemic shock in bovine (with potential application to other mammals)

A new veterinary medicinal composition designed to maintain the oxygenic consumption, to restore hydric, electrolytic and energetic status, as well as the blood pH in affected mammals. More

Generic version of an ultra short acting beta blocker: Esmolol 100mg/10 ml vial

Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More

Swallowing Air-Pulse Therapy System

Western researchers have developed a novel technique, Swallowing Air-Pulse Therapy (SWAPT) and an associated device Swallowing Air-Pulse Therapy System (SWAPTS). More

Seeking channel partners to expand distribution and marketing of information management software systems and services to Europe’s healthcare industry.

US based company with European based operations seeks channel partners to expand marketing and distribution of its information management software products that are designed and developed for blood banks, transfusion centres, hospitals, laboratories, etc More

Generic version of an ultra short acting beta blocker: Esmolol 2500 mg/10 ml ampoule

Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More

Displaying 11..20 of 73 - per page Previous page Next page
Order by

Your selection

Therapeutic target: Hospital and Surgery del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Therapeutic target: Adhesion; Anesthesia; Bleeding; Cosmetic surgery; Dialysis; Disinfectant; Fibrosis; General surgery; Infection control; Infusion; Injection; Intravenous; Irrigation; Perfusion; Plasma expander; Plasma substitute; Surgery (other); Tissue grafting; Transplantation; Wound closure
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us